RICHTER'S SYNDROME
Clinical trials for RICHTER'S SYNDROME explained in plain language.
Never miss a new study
Get alerted when new RICHTER'S SYNDROME trials appear
Sign up with your email to follow new studies for RICHTER'S SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo trial offers hope for tough blood cancers
Disease control OngoingThis study is testing a new drug called epcoritamab to see if it is safe and effective for people with certain hard-to-treat blood cancers. It is for adults with chronic lymphocytic leukemia (CLL) or Richter's syndrome that has come back or not responded to other treatments. The …
Matched conditions: RICHTER'S SYNDROME
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New hope for tough blood cancers: early trial tests promising pill
Disease control OngoingThis study tested a new oral medication called acalabrutinib for adults with chronic lymphocytic leukemia (CLL) and related cancers that have come back or stopped responding to other treatments. The main goals were to find a safe dose and see if the drug could shrink the cancer. …
Matched conditions: RICHTER'S SYNDROME
Phase: PHASE1, PHASE2 • Sponsor: Acerta Pharma BV • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC